Clinical Trial Update: An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus [EARLY_Phase 1]

View source ↗

Summary

This is an early-phase 1 exploratory clinical study evaluating anti-CD19 CAR NK cells for systemic lupus erythematosus and it is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Anti-CD19 CAR-NK cells (Chimeric Antigen Receptor NK cell therapy targeting CD19)

Snippet

Sponsor: Changhai Hospital | Conditions: Systemic Lupus Erythematosus (SLE) | EARLY_Phase 1 | Status: RECRUITING